Picture of Geovax Labs logo

GOVX — Geovax Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

GeoVax Labs Inc expected to post a loss of 77 cents a share - Earnings Preview

* GeoVax Labs Inc  GOVX.OQ   GOVX.O  is expected to show a
rise in
quarterly revenue when it reports  results on February 26
(estimated) for the period ending December 31 2024
    * The Smyrna Georgia-based  company is expected to report
revenue
of $2.38 million, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for GeoVax Labs Inc is for a
loss
of 77 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for GeoVax Labs
Inc
is $15.00​, above​ its last closing price of $1.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -1.43       -1.48      -0.91     Beat    38.4
 Jun. 30 2024  -2.51       -3.36      -1.99     Beat    40.9
 Mar. 31 2024  -5.56       -5.56      -2.47     Beat    55.6​
 Dec. 31 2023  -2.27       -2.78      -13.60    Missed  -389.8
 ​​Sep.        -3.60       -3.60      -4.80     Missed  -33.3
 30 2023                                                
 Jun. 30 2023  -2.45       -2.47      -3.30     Missed  -33.3​
 Mar. 31 2023  -3.05       -3.05      -2.25     Beat    26.2
 Dec. 31 2022  -3.75       -3.00      -3.00     Met     0
 This summary was machine generated February 24 at 22:28 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Geovax Labs

See all news